US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 25.440
  • -1.090-4.11%
Close Feb 14 16:00 ET
  • 26.050
  • +0.610+2.40%
Pre 04:36 ET
1.17BMarket Cap-12.85P/E (TTM)

About Pacira BioSciences Company

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Company Profile

SymbolPCRX
Company NamePacira BioSciences
Listing DateFeb 3, 2011
Issue Price7.00
Founded2006
CEOMr. Frank D. Lee
MarketNASDAQ
Employees712
Fiscal Year Ends12-31
Address5401 West Kennedy Boulevard,Suite 890
CityTampa
ProvinceFlorida
CountryUnited States of America
Zip Code33609
Phone1-813-553-6680

Company Executives

  • Name
  • Position
  • Salary
  • Frank D. Lee
  • Director and Chief Executive Officer
  • --
  • Jonathan Slonin
  • Chief Medical Officer
  • 1.59M
  • Brendan P. Teehan
  • Chief Commercial Officer
  • --
  • Shawn M. Cross
  • Chief Financial Officer
  • --
  • Krys Corbett
  • Chief Business Officer
  • --
  • Kristen Marie Williams
  • Chief Administrative Officer and Secretary
  • 1.60M
  • Lauren Riker
  • Principal Accounting Officer and Senior Vice President, Finance
  • --
  • Daryl Gaugler
  • Executive Vice President, Commercial Operations
  • 1.53M
  • Laura A. Brege
  • Chairman of the Board
  • 364.01K
  • Dr. Mark I. Froin, M.D.
  • Independent Director
  • 349.01K
  • Michael J. Yang
  • Independent Director
  • 427.16K
  • Dr. Marcelo Bigal, M.D.,PhD
  • Independent Director
  • 426.45K
  • Dr. Mark A. Kronenfeld, M.D.
  • Independent Director
  • 373.01K
  • Alethia Young
  • Independent Director
  • 427.86K
  • Governor Christopher J. Christie
  • Independent Director
  • 325.01K
  • Abraham N. Ceesay, M.B.A.
  • Independent Director
  • 427.16K

Trending Stocks

Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More